BIO-CAT Gains Triglyceride-Lowering Patent

TROY, Va.The U.S. Patent and Trademark Office (USPTO) granted BIO-CAT Inc. a patent (no. 8,268,305) for the use of a lipase enzyme to digest dietary fats, resulting in the reduction in levels of triglycerides in the blood stream. BIO-CAT specializes in enzyme applications and the patent was issued Sept. 18, 2012.

The innovation  to use lipase to reduce triglycerides stemmed from previous work completed by BIO-CAT that resulted in a 2011 U.S. using an enzyme  mixture including  lipase to aid in the digestion  of fats and other materials  in the  diet. This  discovery is targeted to  help people,  especially  those  affected by pancreatic insufficiency, cystic fibrosis and other similar ailments, obtain more nutrition from their food.

BIO-CAT said it will be conducting  further clinical studies  to optimize both technologies in order to bring the product to market.

High triglycerides are a major problem for many people, and we knew the lipase enzyme had the ability to break the fats down," said Ed Schuler, CEO, BIO- CAT. "Our innovation is demonstrating the complete breakdown of fats during  digestion in the stomach. This led to further observations where blood triglycerides were substantially reduced in initial test cases."

 Earlier this year, BIO-CAT revamped its website.